PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI) today said it will continue to market its Digoxin Tablets and that the company’s Digoxin product is not subject to the recent FDA announced recall of Digitek®, the brand version of Digoxin Tablets. Lannett’s Digoxin product is manufactured by Jerome Stevens Pharmaceutical and has never been subject to recall.
